biostudies-literatureUnknown197(32)Xu W<h4>Background</h4>Determining optimal timing for intensifying the frequency of physician encounters for type 2 diabetes mellitus (T2DM) requires trade-offs between timely care and clinician burden. We aimed to investigate age-specific cardiovascular disease (CVD) risk thresholds used for intensifying encounter frequency in patients with T2DM in primary care.<h4>Methods</h4>Using population-based public electronic health records from the Hospital Authority Clinical Management System in Hong Kong, we used data from patients with a baseline 10-year CVD risk of lower than 20% and a regular follow-up interval of 4-6 months at public primary care clinics. We compared different CVD risk thresholds (> 20% v. 30%) at which to shorten follow-up intervals to 3 months or less. We investigated age-speCMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienneE1024-E1033https://www.ebi.ac.uk/biostudies/studies/S-EPMC12483090biostudies-literatureCardiovascular risk thresholds for intensifying primary care encounter frequency for patients with type 2 diabetes mellitus: a target trial emulation.PMC12483090Lam CLKTanuseputro PTse ETYWan EYFXu WfalseCardiovascular risk thresholds for intensifying primary care encounter frequency for patients with type 2 diabetes mellitus: a target trial emulation.<h4>Background</h4>Determining optimal timing for intensifying the frequency of physician encounters for type 2 diabetes mellitus (T2DM) requires trade-offs between timely care and clinician burden. We aimed to investigate age-specific cardiovascular disease (CVD) risk thresholds used for intensifying encounter frequency in patients with T2DM in primary care.<h4>Methods</h4>Using population-based public electronic health records from the Hospital Authority Clinical Management System in Hong Kong, we used data from patients with a baseline 10-year CVD risk of lower than 20% and a regular follow-up interval of 4-6 months at public primary care clinics. We compared different CVD risk thresholds (> 20% v. 30%) at which to shorten follow-up intervals to 3 months or less. We investigated age-spe2025-01-01T00:00:00Z2025 Sep2026-06-04T01:25:41.317Z2026-05-03T03:14:05.305ZS-EPMC124830904102247910.1503/cmaj.241703